Each material 8-K filed by a company listed on a US stock exchange (NYSE, Nasdaq, Cboe), read and summarized: what happened, the key numbers, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). This page lists the last 45 days; every brief stays on its company's 8-K page (4787 companies, A–Z).
Arrowhead Pharmaceuticals refinanced its senior secured term loans on November 2, 2026, replacing a 15.0% payment-in-kind facility with a $400.0 million term loan at three-month Term SOFR plus 5.50% that matures November 2, 2031. The existing loans were repaid in full from cash on hand for an aggregate payoff of approximately $404.4 million, a discount of about $68 million from the 2.0x MOIC payment otherwise owed, and the new terms remove required prepayments from plozasiran sales and licensing proceeds. For shareholders, the filing shows lower interest cost, a longer maturity and fewer mandatory repayments, while the company now carries a $400.0 million secured obligation.
New $400.0 million senior secured term loan matures November 2, 2031, with interest at three-month Term SOFR (1.00% floor) plus 5.50%, versus a fixed 15.0% rate paid in kind on the retired loans
Existing loans repaid in full from cash on hand for an aggregate payoff of approximately $404.4 million, which included a discount of about $68 million from the 2.0x MOIC payment
Minimum unrestricted cash covenant reduced to $125.0 million from $150.0 million
New agreement no longer requires prepayment from plozasiran sales, royalties, milestones or pipeline monetizations; the filing says the terms are to be filed with the 10-Q for the quarter ended December 31, 2026
On October 27, 2026, a Diversified Energy subsidiary signed an amendment to its revolving credit agreement. The amendment raises the borrowing base from $900 million to $1 billion and the aggregate maximum credit amounts from $1.5 billion to $2.5 billion, while cutting interest margins by 25 basis points. It also sets an earlier maturity date if the Nordic bonds remain outstanding, which would move the facility's maturity to January 8, 2029.
Borrowing base rises from $900 million to $1 billion; aggregate maximum credit amounts rise from $1.5 billion to $2.5 billion.
Truist Bank replaces KeyBank National Association as administrative agent; KeyBank is no longer a lender.
Interest margins are reduced by 25 basis points; maturity moves to October 27, 2030, or earlier, to January 8, 2029, if the 9.75% Nordic bonds due April 9, 2029 remain outstanding.
On October 26, 2026, ABS IX redeemed its $62 million in asset-backed notes using borrowings under the credit agreement.
DeFi Development Corp. (DFDV) said its SOL and SOL equivalent holdings rose by 5,336 during October 26 to October 30, 2026, to 2,600,948 SOL. The company also said the annual dividend rate on its CHAD preferred stock rose from 13.00% to 14.00%, effective November 2, 2026. For shareholders, the filing reports a larger treasury and a higher preferred dividend rate, but it contains no revenue, earnings or guidance figures.
SOL and SOL equivalents rose from 2,595,612 on October 23, 2026 to 2,600,948 on October 30, 2026, an increase of 5,336 SOL
CHAD Variable Rate Series C Perpetual Preferred Stock dividend rate increased from 13.00% to 14.00%, effective November 2, 2026
At the $10.00 stated amount, the new rate equals $1.40 per share per year, with dividends payable each business day when declared
The company expects SOL held in treasury to be deployed through staking, validator and onchain treasury infrastructure, subject to market conditions
Genasys said it repaid in full the unsecured term loan from Maran Partners Fund, LP, with the final payment of principal and accrued interest made on October 23, 2026. The company says it now has no remaining obligations under that loan and can focus loan servicing on its secured term loan, where it made its first monthly amortization payment on October 1, 2026.
Original borrowing of $4.3 million from Maran Partners on June 9, 2026
Loan amended September 14, 2026, with a partial repayment at that time
Final payment of remaining principal and accrued interest made October 23, 2026
CFO Cassandra Monteon said the company expects to repay the secured term loan on schedule
VolitionRx paid $500,000 in cash toward the principal of its $2.4 million senior secured convertible note held by Lind Global Asset Management XII LLC, leaving a balance of $706,667. Under an October 23, 2026 waiver, Lind agreed not to convert the note before January 1, 2027 unless the closing share price reaches $0.275, and the November and December 2026 repayments were deferred. The company says the moves reduce debt and pause conversion rights, which bear on potential share dilution, though the deferrals show the scheduled payments were pushed back.
$500,000 cash prepayment of principal on the note, with $706,667 remaining outstanding
Lind agreed not to exercise conversion rights on or before January 1, 2027, unless the closing price equals or exceeds $0.275 per share
November and December 2026 monthly repayments deferred and kept in outstanding principal
Waiver dated October 23, 2026; company press release issued October 27, 2026
Soluna Holdings said it repaid in full the $28.7 million in principal outstanding as of June 30, 2026, under its credit facility with Generate Capital, PBC, and the facility has been terminated. The company said the liens on the related project assets have been released, and that total debt principal falls from $37.9 million at June 30, 2026 to $9.2 million, reflecting remaining balances as of that date. The filing contains no income statement or guidance figures.
$19.1 million of Generate debt was repaid in August 2026, and the remainder was paid in October 2026.
The Generate facility was terminated and liens on related project assets were released.
The company states total debt principal falls from $37.9 million at June 30, 2026 to $9.2 million.
Zevia agreed on October 22, 2026 to sell up to $20 million of Series A Senior Convertible Preferred Stock to Bubble Holdings, an affiliate of GP Investments; $15 million closed that day and the remaining $5 million depends on 2026 net sales and Adjusted EBITDA targets. The company also said preliminary third quarter 2026 net sales are about $48 million, above its prior $44 million to $46 million guidance, and Adjusted EBITDA is expected to be between negative $900 thousand and negative $1.0 million, better than its prior negative $3.0 million to negative $3.5 million range, though the convertible preferred is dilutive to common shareholders.
$15 million of Series A Preferred Stock issued October 22, 2026; remaining $5 million deferred closing requires 2026 net sales of at least $172.5 million and Adjusted EBITDA of no less than negative $3.0 million
Preferred accrues a 6.00% dividend and converts initially at $1.448 per share, with conversion capped at 14,428,844 shares
Purchaser gets the right to designate one board director; board size increased to eight members
Preliminary Q3 2026 net sales about $48 million vs. prior guidance of $44 million to $46 million; full results due November 4, 2026
FrontView Operating Partnership, the operating partnership of FrontView REIT, entered Amendment No. 5 to its Credit Agreement on October 15, 2026, extending the maturity of its revolving credit facility and term loans to October 3, 2028. The amendment also lowers certain interest rate margins and replaces the revolver's usage-based commitment fee with a facility fee, which shareholders may see as lower borrowing costs and a longer repayment runway.
Amendment No. 5 dated October 15, 2026, extends the revolving credit facility and term loans to October 3, 2028.
Revolver margins before an investment-grade rating range from 1.00% to 1.65%, down from the prior terms, which the filing does not state.
Revolver usage-based commitment fee replaced with a facility fee of 0.15% to 0.30%, based on leverage ratio, before an investment-grade rating.
Full terms will be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026.
Blue Owl Finance LLC, an indirect subsidiary of Blue Owl Capital Inc., signed a fourth amendment to its credit agreement on October 14, 2026. The revolving credit commitment rises to $3,225,000,000 (potentially $3,870,000,000 if conditions are met), the maturity is extended to October 14, 2031, and pricing is reduced, which lowers borrowing costs for the subsidiary.
Revolving commitment increased to $3.225 billion, with a potential increase to $3.87 billion if conditions are satisfied
Maturity extended from the existing date to October 14, 2031
Term SOFR loan margin reduced to 77.5 to 127.5 basis points; commitment fee rate reduced to 7.0 to 16.5 basis points
MUFG Bank, Ltd. serves as administrative agent; the Company itself is not a party to the amended agreement
StubHub Holdings amended its credit agreement on October 14, 2026, extending the maturity of its USD and Euro Term Loan Bs from March 15, 2030 to October 14, 2033. The company also shifted the mix between dollar and euro term loans and extended part of its revolving credit facility to 2031. The company says the amendment lowers its term loan borrowing costs by 25 basis points and pushes out its debt maturities.
USD Term Loan B increased from approximately $804 million to approximately $975 million; Euro Term Loan B reduced from approximately €452 million to approximately €300 million
Term loan maturities extended from March 15, 2030 to October 14, 2033; the company states the total term loan amount is unchanged
Margin on the USD Term Loan B is 4.50% and on the Euro Term Loan B is 4.75%; the company cites a 25-basis-point reduction in borrowing costs
$425 million of the $565 million Revolving Credit Facility is now scheduled to mature on October 14, 2031; $140 million remains due September 30, 2030
Reliance Global Group said it repaid in full its Oak Street Funding term loan, its only term debt, leaving no outstanding term debt. The loan had a balance of about $4.4 million as of June 30, 2026, and the repayment was funded by proceeds from two agency sales and collateral cash, without issuing shares. The company reports more than $6 million of cash after the repayment and says it eliminates about $1 million of annual principal, interest and fee payments.
Oak Street Funding term loan repaid in full; balance was about $4.4 million as of June 30, 2026.
Funding: about $1.2 million from the Southwestern Montana Insurance Center sale (closed September 11, 2026), about $2.2 million from the Altruis Benefit Consulting sale (closed September 24, 2026), and about $1.0 million of collateral cash.
Eliminates about $1 million of annual principal, interest and fee payments; company reports more than $6 million of cash on its balance sheet afterward.
PowerCompute reported preliminary, unaudited September 2026 operating results and said it repaid its Arch Bitcoin-backed credit facility in full using 267.4 Bitcoin, releasing all pledged collateral. The company mined 8.1 Bitcoin in September, up 37% from September 2025, and generated about $312,000 of energy sales over the three months ended September 30, 2026. For shareholders, secured debt fell from $23.70 million to $1.25 million, while Bitcoin held dropped to 63.7 BTC from 323.02 BTC.
Mined 8.1 BTC in September 2026, up 37% from 5.9 BTC in September 2025 and up 2.7% from 7.9 BTC in August 2026.
Applied 267.4 BTC to repay about $22.45 million of principal and accrued interest under the Arch credit facility, reducing total secured debt from $23.70 million to $1.25 million.
Energy sales of about $89,000 in September 2026 and about $312,000 for the three months ended September 30, 2026, from selling power during heat-related curtailment in Oklahoma and Mississippi.
Bitcoin held fell to 63.7 BTC at September 30, 2026, from 323.02 BTC at August 31, 2026, valued at about $5.3 million.
TETRA Technologies signed a First Amendment to its term loan credit agreement on October 2, 2026. The amendment lowers the loan's interest rate by 0.75 percentage points, extends maturity to December 31, 2030, and pauses scheduled principal payments until June 30, 2028.
Interest rate reduced from SOFR + 5.75% to SOFR + 5.00% per annum
Maturity extended from January 12, 2030 to December 31, 2030
Scheduled amortization payments suspended until June 30, 2028; TETRA Bromine Project LLC required to become a guarantor
Magnite amended its credit agreement on October 7, 2026, cutting the interest margin on its $358 million term loan by 50 basis points to Term SOFR + 2.50%. The margin on its $175 million revolving credit facility also fell, to a range of Term SOFR + 2.50% to 3.00%, and the company estimates about $1.8 million in annualized cash interest savings. Maturities are unchanged, so the change lowers borrowing costs without altering the loan terms' timing.
Term loan margin cut 50 basis points to Term SOFR + 2.50%, from Term SOFR + 3.00%
Revolver margin range lowered to Term SOFR + 2.50%-3.00%, from 3.50%-4.00%
Company estimates about $1.8 million in annualized cash interest savings
Term loan maturity remains February 2031; revolver matures February 2029
Blue Bird Corporation entered into a Second Amendment to its Credit Agreement, raising total committed facilities to $600 million from $250 million and extending maturity to September 30, 2031. Pricing falls to SOFR plus 1.25% to 2.25%, based on leverage, from SOFR plus 1.75% to 3.25%, and the new delayed draw term loan can fund capital projects, research and development, working capital, or refinance existing debt. The maximum total net leverage ratio rises to 3.25x, and the company also closed a separate Canadian dollar line for its Micro Bird unit.
Total facilities rise to $600 million from $250 million, including a $300 million revolver (up from $150 million) and a $300 million delayed draw term loan
Maturity extended from November 17, 2028 to September 30, 2031
Margin lowered to SOFR plus 1.25% to 2.25% from SOFR plus 1.75% to 3.25%; 0.10% credit spread adjustment eliminated
At closing, about $86 million was carried over as drawn debt, with $214 million available to draw under the Borrower's facilities and $670+ million of liquidity per the press release
Surrozen said the FDA cleared its Investigational New Drug application for SZN-8141, a treatment for diabetic macular edema, allowing clinical development to advance. The clearance satisfies a milestone for the second closing of its March 2025 private placement, which is expected to bring about $95.1 million in gross proceeds on or about October 20, 2026, before placement agent fees and other expenses.
FDA clearance of the SZN-8141 IND took effect after the statutory 30-day review period, announced October 2, 2026
First patient dosing in the Phase 1b/2a DUET study is expected in Q4 2026, with initial data expected in 2H 2027
Second closing of the March 2025 two-tranche private placement expected on or about October 20, 2026, with approximately $95.1 million in gross proceeds
Surrozen must file a Form S-3 resale registration statement within 30 calendar days after the closing
Hyperion DeFi, formerly Eyenovia, repaid its Avenue Capital loan in full on September 28, 2026, paying about $8.6 million with no early termination penalty, and says it has no long-term debt outstanding. The repayment was funded partly by sales of HYPE tokens, and the company has also begun repurchasing its common stock. The $14.5 million cash figure it reported is preliminary and unaudited.
September 28, 2026: repaid the Loan Agreement with Avenue Capital in full for about $8.6 million; liens were released and no early termination penalty was incurred.
Repayment was funded by HYPE token sales and cash on hand; 200,000 HYPE and HYPE liquid staking tokens were sold in the quarter ended September 30, 2026.
Repurchased 240,124 HYPD common shares at a weighted average gross price of $3.21 per share, as announced October 2, 2026.
As of September 30, 2026, cash, cash equivalents and USDC stablecoin totaled about $14.5 million (preliminary, unaudited); the company held 1.85 million Gross HYPE tokens.
Carriage Services entered a five-year, $300 million senior secured revolving credit facility led by JPMorgan Chase, which replaces its $250 million facility, and terminated its $100 million at-the-market equity offering program effective October 4, 2026. The company says the new facility lowers borrowing costs and adds liquidity, and that it is lowering its targeted leverage range to 3.0x–3.5x. The facility is secured by a first-priority lien on substantially all company and subsidiary guarantor assets.
Revolving credit facility of up to $300 million, with an optional $100 million accordion feature that no lender is obligated to fund
Replaces the $250 million facility from May 2021; the company says the new facility expands capacity and reduces borrowing spreads
$100 million at-the-market equity program terminated effective October 4, 2026
Targeted leverage ratio lowered from 3.5x–4.0x to 3.0x–3.5x; $400 million of 4.25% Senior Notes mature in May 2029
PowerCompute said its Bitcoin-backed credit facility with Arch Lending was settled on September 24, 2026, its scheduled reset date, and was not triggered by a margin call or forced liquidation. The company says secured debt fell about 94%, from about $19.4 million at June 30, 2026 to about $1.25 million, and that no Bitcoin remains pledged, which it expects to lower interest and collar-related expense.
Arch facility settled September 24, 2026, with $21,892,132 principal, $118,582 accrued interest and a $440,122 fee covered by sale of about 267.3 of 307 pledged Bitcoin
About 39.6 Bitcoin returned to the company; no Bitcoin remains pledged as collateral
Secured debt fell from about $19.4 million at June 30, 2026 to about $1.25 million, a reduction of about 94%
Remaining secured promissory note matures December 31, 2026 and is not secured by Bitcoin
Power Solutions International (PSI) entered a new $220 million committed revolving credit agreement with HSBC as administrative agent, maturing September 25, 2029, and used part of it to repay in full its prior $135 million facility with Standard Chartered Bank. The new facility carries a lower borrowing spread of SOFR plus 1.80% versus SOFR plus 2.60% under the prior facility, and the company borrowed $35.0 million at closing, which shareholders may track as new debt secured by substantially all company and guarantor assets.
Committed capacity rises from $135 million to $220 million, with a $70 million letter of credit sublimit and expiry on September 25, 2029.
Borrowing rate is SOFR plus 1.80% per annum, down from SOFR plus 2.60% under the prior facility.
The company borrowed $35.0 million at closing and repaid about $15.1 million under the prior facility, with no early termination penalties.
Covenants require an interest coverage ratio of at least 3.00 to 1.00 and a leverage ratio of no more than 3.00 to 1.00, tested quarterly; a change of control default applies under specified Weichai conditions.
Pitney Bowes and its subsidiaries amended their credit agreement on September 29, 2026, reducing the interest rate margin on $585.5 million of tranche B term loans by 75 basis points. The company expects the change to cut annual interest expense by about $4 million, and the March 2032 maturity and other terms are unchanged.
Tranche B term loans outstanding of $585.5 million; margin cut from 375 to 300 basis points over Term SOFR, or 3.00%, and 2.00% for Base Rate loans
Company expects annual interest expense to fall by about $4 million based on the current principal balance
Maturity date (March 2032) and other loan terms unchanged, per the press release
S&P Global Ratings upgraded the issuer credit rating to 'BB-' from 'B+'
On September 25, 2026, Angel Oak Mortgage REIT and two subsidiaries extended a loan financing facility with lender Global Investment Bank 3 through September 25, 2027. The filing says the interest rate pricing spread was reduced, with the low end falling from 1.75% to 1.35% while the stated top of the range stayed at 4.75%, which could lower borrowing costs for shareholders.
Facility extended through September 25, 2027
Pricing spread range changed from 1.75% to 4.75% to 1.35% to 4.75%
Sixth Amendment to Second Amended and Restated Master Repurchase Agreement filed as Exhibit 10.1, dated September 25, 2026, with portions redacted
On September 25, 2026, Angel Oak Mortgage REIT and two subsidiaries extended their loan financing facility with lender Multinational Bank 1 through December 28, 2026, the facility had been set to expire on September 25. The interest rate pricing spread was reduced to a range of 1.20% to 2.10%, from 1.30% to 2.10%, which lowers the bottom of the borrowing cost range.
Facility extended to December 28, 2026, from an original expiry of September 25, 2026
Interest rate pricing spread reduced to 1.20% to 2.10%, from 1.30% to 2.10%
Extension was made under an agreement that contemplates rolling three-month renewals with Multinational Bank 1
Fate Therapeutics said the California Institute for Regenerative Medicine awarded it a $15.0 million grant through its CLIN2 program to support the Phase 2 RECLAIM-LN trial of FT819 in lupus nephritis. The filing does not state financial results or any change to company guidance, so the grant's direct effect on shareholders is not quantified.
CIRM awarded a $15.0 million grant on September 25, 2026, under its CLIN2 program.
The grant supports the Phase 2 RECLAIM-LN trial of FT819 in refractory lupus nephritis.
The trial is expected to enroll approximately 53 patients; the primary endpoint is complete renal response at Week 26.
Generation Income Properties said LC2, an affiliate of Loci Capital Partners, confirmed on September 24, 2026 that its preferred equity investment in GIP SPE, LLC has been fully redeemed for $4,160,217, funded mainly by net proceeds from a warrant exercise disclosed on September 21, 2026. The company said the redemption removes the preferred investment from its balance sheet, while its Nasdaq bid price compliance requirement remains outstanding.
LC2 confirmed full redemption on September 24, 2026 of the remaining preferred equity in GIP SPE, LLC.
Total remaining redemption payment and costs were $4,160,217, funded principally by net proceeds from the warrant exercise disclosed September 21, 2026.
The original $14.1 million preferred investment from LC2 was partial financing for the August 2023 purchase of properties from Modiv Inc.
The company must still maintain a closing bid price of at least $1.00 per share for Nasdaq compliance and says a reverse stock split is available if necessary.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Frequently asked questions
Which filings get a brief?
Form 8-K filings by companies listed on a US stock exchange (NYSE, Nasdaq, Cboe; not over-the-counter stocks) that report a material event: results (Item 2.02), deals (1.01, 2.01), executive changes (5.02), restructuring (2.05), impairments (2.06), delisting notices (3.01), restatements (4.02), cybersecurity incidents (1.05), bankruptcy (1.03) and Regulation FD or other events (7.01, 8.01). Routine filings such as vote results or exhibits only are skipped.
How is the impact score set?
The AI rates each filing from 1 (routine) to 5 (major, such as a merger, bankruptcy or restatement) based only on what the filing says. It is a reading aid for sorting the day's filings, not a prediction of how the stock will move.
How quickly do briefs appear?
On weekdays the SEC filing feed is checked every 5 minutes from 6 am to 5:45 pm Eastern, when nearly all 8-Ks come in, and every hour after that until 10 pm. Briefs of the 1,000 largest companies follow within minutes; the others usually within the hour, or later the same day when many filings arrive at once.
Which companies are covered?
Every company with shares listed on the NYSE, Nasdaq or Cboe that files 8-Ks, about 4,500 of them. Foreign companies that report on Form 6-K instead are not included. The S&P 1500 only filter above narrows the list to the large, mid and small caps of the S&P Composite 1500.
Are older briefs kept?
Yes. This page shows the last 45 days, but every brief ever published stays online: each has its own page, and each company has an 8-K page listing all of its briefs, newest first, linked from its stock page and from the A-Z list of companies.